Professor Celia Morgan

Professor Celia Morgan is Co-Founder of the EPIC, where she leads the clinical applications strand of the research programme. Her work focuses on understanding how context shapes the effects of psychoactive substances and why the same drug can produce vastly different outcomes depending on the setting in which it is used.

Her research spans two interconnected areas: the psychology of addiction, particularly how relationships with substances become overvalued and entrenched, and the clinical application of psychedelic drugs alongside psychological therapies. She has led large-scale clinical trials of ketamine-assisted therapy and continues to explore how these treatments can be delivered safely and effectively.

Across behavioural studies, neuroimaging, and clinical trials, her work aims to develop a more nuanced understanding of how substances affect the mind, moving beyond reductionist models to better reflect the complexity of human experience.